Skip to content
Biodatica
Start free

BicycleTx Limited

Encinitas, California

OncologyPhase II
Compare Sign in to watch

What changed

Phase II trial registered: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

8mo agoTrial registeredNov 17, 2025Source filing (opens the source filing in a new tab)

Momentum

58no change

Momentum 58 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1/PHASE2 registered

    Jul 17, 2020

    Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms, Breast Neoplasms, Non-Small-Cell Lung Neoplasms, Ovarian Neoplasm, Advanced Solid Tumor · ACTIVE_NOT_RECRUITING · sponsor: BicycleTx Limited · Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

    ClinicalTrials.gov · NCT04561362 (opens the source filing in a new tab)

  2. Trial

    PHASE1/PHASE2 registered

    Nov 7, 2019

    Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer, Head and Neck Cancer, Triple Negative Breast Cancer, Gastric/Upper Gastrointestinal Cancer · ACTIVE_NOT_RECRUITING · sponsor: BicycleTx Limited · Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

    ClinicalTrials.gov · NCT04180371 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources